Yann LeCun and Moderna's Bob Langer join Cellular Intelligence board to bring AI into medicine
arjunrajlab · x · 2026-09-22
Cellular Intelligence, a startup building AI models that predict and eventually control living cell behavior to speed up drug development (starting with a Parkinson's drug), announced that Turing Award winner Yann LeCun, Moderna co-founder Bob Langer, Jens Nielsen, and Fabian Theis joined its scientific advisory board, with Langer also joining the board as observer. The move follows LeCun's recent shift away from Meta toward world-model research.
Related event: Yann LeCun and Moderna co-founder join Cellular Intelligence(3 posts)→
More from Companies & People
- VentureTwins maps the B2A economy: dozens of agent infra and app companies in first series installment — venturetwins · 2026-11-12
- How DoorDash's GenAI platform team lets engineers build with AI quickly and safely — charles_irl · 2026-11-12
- Databricks launches autonomous AI coworker Genie: 91% on enterprise tasks with half the tokens — Yuchenj_UW · 2026-11-12
- Anthropic Lead SWE makes ~10x a GS-13's pay — called a national security blunder — harris_edouard · 2026-11-12
- a16z podcast: Mike Volpi on Cisco's 70+ acquisition playbook and the AI buildout — a16z · 2026-11-12
- Is Jensen Huang's bad behavior more commonplace than it seems? TechCrunch investigates — TechCrunch AI · 2026-11-12